Keyword: Drug Development

News

Bernard Pluta Appointed as President of Recipharm’s Development Services

22.02.2018 - Sweden-based drug developer and toll manufacturer Recipharm has appointed Bernard Pluta to lead its new global development organization, which is to be implemented during the first...

News

Ergomed Buys Dutch-based PSR Group

05.10.2017 - UK pharmaceutical company Ergomed has acquired PSR Group, a Dutch contract research organization (CRO) that specializes in orphan drug development and is regarded as a leading...

Plant Construction & Process Technology

ISPE Recognizes Leaders in Drug Shortage Prevention

12.09.2016 - The International Society for Pharmaceutical Engineering (ISPE) recognized 2016 category winners Baxter BioPharma Solutions and Janssen Vaccines for their exceptional leadership in...

Plant Construction & Process Technology

Opportunities in Drug Development and Manufacturing

12.09.2016 -

Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active...

News

Recipharm Acquires Italy’s Mitim

26.02.2016 - Swedish drug developer and toll manufacturer Recipharm has acquired Italian contract company Mitim for €68 million. The acquisition of the family-owned firm, which is located in...

News

Lonza Expands Drug Product Services

04.02.2016 - Swiss fine and specialty chemical producer Lonza is building up its capabilities for drug development and manufacturing services to meet customers’ clinical outsourcing needs. The...

Chemistry & Life Sciences

DCAT Week ’16

03.02.2016 - A key upcoming industry event is DCAT Week, the flagship event of the Drug, Chemical & Associated Technologies Association (DCAT). DCAT Week brings together pharmaceutical and...

Research & Innovation

Route Planner for Research Chemists

29.01.2016 - Time is money; this holds particularly true for drug research and development. The global pharmaceutical industry spends about $100 billion a year on R&D. Researchers are...